Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Expand Study-Pharmacist Administered Long Acting Cabotegravir + Rilpivirine to Expand Access for People With HIV

NCT06635421 is registered in ClinicalTrials.gov with MetroHealth Medical Center as lead sponsor.

NCT NCT06635421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06635421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Expand Study-Pharmacist Administered Long Acting Cabotegravir + Rilpivirine to Expand Access for People With HIV
Lead sponsor
MetroHealth Medical Center
Phase
Observational
Overall status
Not yet recruiting
Start date
November 1, 2024
Completion date
December 31, 2026
Enrollment
164 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hiv i infection